Apricot Capital

Portfolio Co Investors 2026 for Apricot Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Apricot Capital accounts for 10 tracked companies with verified cap-table data, 10 of which disclose round sizes totalling $1.1B. The median disclosed raise is $100M, and the largest is ClinChoice Kunling at $212M, ahead of ClinChoiceKunling ($212M) and Sinovent ($145M).

The names that recur most often on these co-invested cap tables are Apricot Capital (10 companies), Legend Capital (4 companies), Taikang Life Insurance (2 companies), Sherpa Healthcare Partners (2 companies), Lilly Asia Ventures (2 companies), Goldman Sachs (2 companies). By latest disclosed round, the market skews Series E (3), Series A (3), Series B (2), Seed (1).

Best funded Apricot Capital companies

  1. ClinChoice Kunling — $212M (latest: Series E)
  2. ClinChoiceKunling — $212M (latest: Series E)
  3. Sinovent — $145M (latest: Series E)
  4. Medilink Therapeutics — $120M (latest: Series B)
  5. Vibrant — $100M
  6. Qihe Biotech — $91M (latest: Series A)
  7. Excalipoint Therapetics — $69M (latest: Seed)
  8. Neowise — $58M (latest: Series B)
  9. Vivatides Therapeutics — $54M (latest: Series A)
  10. Zhiran Medical — $43M (latest: Series A)

Apricot Capital — related firms and companies (53)

Apricot Capital alternatives · All research reports